Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
74 studies found for:    Alkermes | United States
Show Display Options
Rank Status Study
1 Completed A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults
Condition: Multiple Sclerosis
Interventions: Drug: Study Drug;   Drug: Active Control;   Drug: Placebo
2 Completed A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
Condition: Healthy Volunteers
Interventions: Drug: Samidorphan;   Drug: Placebo;   Drug: Oxycodone
3 Completed A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
Condition: Healthy
Interventions: Drug: ALKS 5461;   Drug: Buprenorphine;   Drug: Placebo
4 Completed A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers
Condition: Healthy Volunteers
Intervention: Drug: ALKS 5461
5 Completed A Water Consumption Study of ALKS 5461 in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ALKS 5461
6 Completed A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers
Condition: Healthy
Interventions: Drug: Samidorphan IV;   Drug: [14c]-Samidorphan sublingual;   Drug: [14c]-Samidorphan oral
7 Completed A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Moxifloxacin;   Drug: ALKS 5461;   Drug: Placebo
8 Recruiting A Study of the Effects of ALKS 4230 on Subjects With Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: ALKS 4230
9 Completed ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
Condition: Cocaine Abuse
Interventions: Drug: ALKS 33-BUP;   Drug: ALKS 33;   Drug: Placebo
10 Recruiting An Insulin Sensitivity Study in Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: ALKS 3831;   Drug: Olanzapine;   Drug: Placebo
11 Completed Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function
Condition: Hepatic Impairment
Intervention: Drug: ALKS 5461
12 Completed A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers
Condition: Pharmacokinetics
Interventions: Drug: Itraconazole;   Drug: ALKS 5461
13 Completed A Study of ALKS 5461 in Healthy Volunteers
Condition: Pharmacokinetics
Interventions: Drug: ALKS 5461;   Drug: Placebo
14 Completed
Has Results
ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Placebo;   Drug: TrIP-2D;   Drug: TrIP-2SS;   Drug: TrIP-2SS + Foradil
15 Completed A Phase 1 Safety Study in Adults With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: ALKS 3831
16 Enrolling by invitation A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: ALKS 3831
17 Completed Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function
Condition: Renal Impairment
Intervention: Drug: ALKS 5461
18 Completed
Has Results
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Condition: Opioid Dependence
Intervention: Drug: VIVITROL 380mg
19 Active, not recruiting Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
Condition: Opioid Use Disorder
Interventions: Drug: Naltrexone;   Drug: Placebo;   Drug: Buprenorphine
20 Terminated Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery
Condition: Laparoscopic Surgery
Interventions: Drug: N1539;   Drug: Ketorolac Tromethamine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.